$19.3 Bn Clinical Chemistry Analyzers Industry Overview 2024 and Forecasts to 2030 [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "Clinical Chemistry Analyzers - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global Clinical Chemistry Analyzers market is estimated at US$14.5 billion in 2024 and is expected to record a CAGR of 4.9% during the 2024-2030 analysis period and stand at a projected US$19.3 billion by 2030. The clinical chemistry analyzers market growth is driven by the rising prevalence of chronic conditions such as diabetes, cardiovascular diseases, and kidney disorders, which increase patient visits and diagnostic procedures, thereby boosting demand for these analyzers. Technological advancements like automation, enhanced resolution, and AI integration have improved the capabilities of these analyzers, enabling early disease detection and efficient testing. These innovations enhance accuracy, decrease processing times, and manage large sample quantities, leading to higher demand and market expansion. Addit
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- WHO approves Abbott's mpox test for emergency use [Yahoo! Finance]Yahoo! Finance
- WHO approves first mpox diagnostic test for emergency use [Seeking Alpha]Seeking Alpha
- Enzyme-Linked Immunosorbent Assay (ELISA) Market to Grow by USD 843.9 Million (2024-2028) as AI Drives Demand for Frequent Diagnostic Testing [Yahoo! Finance]Yahoo! Finance
- WHO approves first mpox diagnostic test for emergency use [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Food inflation crisis may be over, but high prices are here to stay [Financial Post (Toronto, Ontario, Canada)]Financial Post
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- ABT's page on the SEC website